JPRN-UMIN000037138招募中未知
A pilot study; The relationship between blood test during cardiopulmonary bypass and coagulation function evaluated by thromboelastometry after taking off cardiopulmonary bypass. - A pilot study; The relationship between blood test during cardiopulmonary bypass and coagulation function evaluated by thromboelastometry after taking off cardiopulmonary bypass.
agoya University Hospital0 个研究点目标入组 50 人开始时间: 2019年7月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
尚未招募
Unknown
Correlation of the blood test results between fingertip blood samples collected with multifunctional microliter-scale blood collection tube and conventional venous or arterial bloodThis study can make blood samplig to be minimally invasive.JPRN-jRCT1032220431Aoyagi Jun20
已完成
不适用
A study examining the relationship between blood flow waveform indices and lifestyle-related disease indicesHealthy adultsJPRN-UMIN000045013Kao Corporation200
已完成
不适用
A clinical study on the correlation between blood glucose level and glucose concentration in aqueous humor of cataract surgery patientsCataractJPRN-UMIN000017362Department of Ophthalmology, Keio University School of Medicine10
进行中（未招募）
不适用
Evaluation of the pharmacodynamic effect of the combination of Sildenafil and Riociguat on blood pressure and other safety parametersMedDRA version: 14.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary arterial hypertensionEUCTR2010-018863-40-DEBayer HealthCare AG18
进行中（未招募）
不适用
An interaction study to evaluate changes in blood pressure following 1, 1.5, 2, and 2.5 mg riociguat tid (dose titration) compared to placebo treatment on the background of stable sildenafil pretreatment in subjects with symptomatic pulmonary arterial hypertension - PATENT PLUSPulmonary arterial hypertension.MedDRA version: 9.1Level: LLTClassification code 10064911EUCTR2010-018863-40-ITBayer Health Care AG36